Anti-beta 2 Microglobulin antibody [EPR21752-214]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(11 Publications)
Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) is a rabbit monoclonal antibody detecting beta 2 Microglobulin in Western Blot, Flow Cytometry (Intra), IP, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
CDABP0092, HDCMA22P, B2M, Beta-2-microglobulin
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Immunohistochemical analysis of paraffin-embedded human spleen tissue labeling beta 2 Microglobulin with ab218230 at 1/4000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP) secondary antibody. Positive staining on endothelial cells of human spleen is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HepG2 (human liver hepatocellular carcinoma cell line) cell line labeling beta 2 Microglobulinwith ab218230 at 1/500 dilution (red) compared with a Rabbit monoclonal IgG - Isotype control (ab172730) (black) and an unlabeled control cells incubatedwith secondary antibody only) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling beta 2 Microglobulinwith ab218230 at 1/50 dilution (red) compared with a Rabbit monoclonal IgG - Isotype control (ab172730) (black) and an unlabeled control (cells incubatedwith secondary antibody only) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Immunohistochemical analysis of paraffin-embedded human kidney tissue labeling beta 2 Microglobulin with ab218230 at 1/4000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP) secondary antibody. Positive staining on endothelial cells of human kidney is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Unknown
Immunoprecipitation - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Beta 2 Microglobulin was immunoprecipitated from 0.35 mg HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab218230 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218230 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab218230 IP in HeLa whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab218230 in HeLa whole cell lysate (-).
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230)
Predicted band size: 14 kDa
false
- WB
Unknown
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Blocking/diluting buffer and concentration : 5% NFDM/TBST.
Exposure times : Lane 1 : 6 seconds; Lane 2-3 : 37 seconds : Lane 4-7 : 48 seconds; Lane 8-11 : 3 minutes.
Lanes 4-11 : This blot was developed using a higher sensitive ECL substrate.
All lanes:
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Lane 2:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 10 µg
Lane 3:
HepG2 (human liver hepatocellular carcinoma cell line) cell lysate at 10 µg
Lane 4:
Mouse serum at 10 µg
Lane 5:
Mouse plasma at 10 µg
Lane 6:
Rat serum at 10 µg
Lane 7:
Rat plasma at 10 µg
Lane 8:
Human plasma at 10 µg
Lane 9:
Human skin lysate at 10 µg
Lane 10:
Human kidney lysate at 10 µg
Lane 11:
Human liver lysate at 10 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Lanes 4 - 11:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 14 kDa
false
- WB
Lab
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
False colour image of Western blot : Anti-beta 2 Microglobulin antibody [EPR21752-214] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab218230 was shown to bind specifically to beta 2 Microglobulin. A band was observed at 12 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in B2M knockout cell line ab266828 (knockout cell lysate ab256845). To generate this image, wild-type and B2M knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
B2M knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human B2M (beta 2 Microglobulin) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-b2m-beta-2-microglobulin-knockout-hek-293t-cell-line-ab266828'>ab266828</a>)
Lane 3:
Wild-type A431 cell lysate at 20 µg
Lane 4:
B2M knockout A431 cell lysate at 20 µg
Predicted band size: 14 kDa
Observed band size: 12 kDa
false
- WB
Lab
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (AB218230)
Lanes 1-4 : Merged signal (red and green). Green - ab218230 observed at 14 kDa. Red - loading control ab8245 observed at 36 kDa.
ab218230 Anti-beta 2 Microglobulin antibody [EPR21752-214] was shown to specifically react with beta 2 Microglobulin in wild-type HepG2 cells. Loss of signal was observed when knockout cell line ab262325 (knockout cell lysate ab256846) was used. Wild-type and beta 2 Microglobulin knockout samples were subjected to SDS-PAGE. ab218230 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) at 1/500 dilution
Lane 1:
Wild-type HepG2 cell lysate at 20 µg
Lane 2:
B2M knockout HepG2 cell lysate at 20 µg
Lane 2:
Western blot - Human B2M (beta 2 Microglobulin) knockout Hep G2 cell line (<a href='/en-us/products/cell-lines/human-b2m-beta-2-microglobulin-knockout-hep-g2-cell-line-ab262325'>ab262325</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 14 kDa
Observed band size: 14 kDa
false
Related conjugates and formulations (1)
-
Anti-beta 2 Microglobulin antibody [EPR21752-214] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
What is the molecular weight of beta 2 Microglobulin?
Anti-beta 2 Microglobulin [EPR21752-214] (ab218230) specifically detects a band for beta 2 Microglobulin (UniProt: P61769) at a molecular weight of 14kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-beta 2 Microglobulin antibody [EPR21752-214] (ab218230) has been confirmed by Western blot testing in B2M Knockout HEPG2 cell line, ab266828.
Other related products
We have a range of other formats of antibody clone [EPR21752-214] also available for your convenience: ab218230, Carrier free - ab237032
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Beta-2-microglobulin is important for the stability and transport of MHC class I molecules to the cell surface. As part of the MHC class I complex B2M assists in binding peptides allowing immune cells to identify and target pathogen-infected cells. Without B2M the MHC class I molecules are not properly expressed on the cell surface disrupting immune recognition. In laboratory settings researchers often use anti-beta-2-microglobulin antibodies to investigate its role in MHC class I function.
Pathways
Beta-2-microglobulin interacts significantly with the immune system most notably in the antigen processing and presentation pathway. It works alongside proteins such as the heavy chain of MHC class I. B2M is important in the pathway that involves the transport of antigens to the endoplasmic reticulum where they are loaded onto MHC class I molecules for inspection by cytotoxic T cells. Another related pathway is the tapasin-mediated processing of antigen peptides highlighting the indispensable role of B2M in immune response regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Cell reports. Medicine 6:102076 PubMed40239619
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 134: PubMed38426503
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 12: PubMed38272563
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genes 14: PubMed37628607
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:2041 PubMed37041154
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical & translational immunology 11:e1430 PubMed36452477
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 132: PubMed35230972
2022
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 55:308-323.e9 PubMed34800368
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 28:227-237 PubMed34667030
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:1501-1513 PubMed32700748
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com